This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing Daybue in the commercial setting and ongoing trends in Rett Syndrome
Ticker(s): ACADWho's the expert?
Institution: Boston Children's Hospital
- Pediatric Neurologist & Director of the Comprehensive Rett Syndrome Program at Boston Children’s Hospital, one of 18 IRSF designated Centers of Excellence.
- Sees over 100 patients with Rett syndrome and Rett-related disorders each year.
- Principle Investigator for the Phase 2 study of blarcamesine in adult women with Rett syndrome.
Interview GoalDiscuss Daybue coverage, discontinuations, tolerability, etc in the commercial setting
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
